Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» SGNT's 30-Y Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q4 2015

SGNT Guru Trades in Q4 2015

Paul Tudor Jones 25,829 sh (New)
Steven Cohen 191,600 sh (-16.51%)
» More
Q1 2016

SGNT Guru Trades in Q1 2016

Steven Cohen 118,100 sh (-38.36%)
Paul Tudor Jones 11,664 sh (-54.84%)
» More
Q2 2016

SGNT Guru Trades in Q2 2016

NWQ Managers 1,243,252 sh (New)
Steven Cohen Sold Out
Paul Tudor Jones Sold Out
» More
Q3 2016

SGNT Guru Trades in Q3 2016

NWQ Managers Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with SGNT

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Drug Manufacturers » Drug Manufacturers - Specialty & Generic  
Compare:NYSE:LCI, SZSE:002750, SHSE:603079, BOM:530549, HKSE:02877, SZSE:300534, TSX:APH, TSX:LEAF, OSTO:BIOG B, SHSE:600530, NAS:FLXN, XKRX:001060, SZSE:000790, XKRX:000640, ADX:JULPHAR, SZSE:000597, TPE:1707, TSE:4553, TSX:ACB, SZSE:002728 » details
Headquarter Location:USA
Sagent Pharmaceuticals Inc is a specialty pharmaceutical company. The Company is engaged in developing, manufacturing, sourcing and marketing injectable pharmaceutical products which it sells in the United States of America.

Sagent Pharmaceuticals Inc is a Delaware corporation that was incorporated in 2011. The Company was initially founded in 2006 as Sagent Holding Co., a Cayman Islands company, it reincorporated as Sagent Pharmaceuticals, Inc., a Delaware corporation, in connection with its initial public offering, on April 26, 2011. The Company is engaged in the developing, manufacturing, sourcing and marketing injectable pharmaceutical products, which it sells primarily in the United States of America. The Company primarily focuses on generic injectable pharmaceuticals, which provide customers a lower-cost alternative to branded products when applicable patents have expired or been declared invalid, or when the products are determined not to infringe the patents of others, it offers customers, products across anti-infective, oncolytic and critical care indications in a variety of presentations, including single- and multi-dose vials and ready-to-use pre-filled syringes and premix bags. It generally seeks to develop injectable products where the form or packaging of the product can be enhanced to improve delivery, product safety or end-user convenience. At the year end, the Company's product portfolio has grown to a total of 53 products which can be classified into the following three product categories: anti-infective, oncology and critical care. Its anti-infective products assist in the treatment of various infections and related symptoms, its oncology products are used in the treatment of cancer and cancer-related medical problems, and its critical care products are used in a variety of critical care applications and include anesthetics, cardiac medications, steroidal products and sedatives. The Company distributes its products primarily through pharmaceutical wholesalers and, to a lesser extent, specialty distributors that focus on particular therapeutic product categories, for use by a wide variety of end-users, including U.S. hospitals, integrated delivery networks and alternative site facilities. The Company's principal competitors include Fresenius Kabi, a division of Fresenius SE, Hospira, Inc., Pfizer Inc., Sandoz International GmbH, a division of Novartis AG, Teva Pharmaceutical Industries Ltd. and West-Ward Pharmaceutical Corp. The Company is subject to extensive regulation by governmental authorities in the U.S. and in other countries.



Buy Back


Valuation & Return


More Statistics

Revenue (TTM) (Mil) $297.82
EPS (TTM) $ -0.77
Short Percentage of Float4.75%
52-Week Range $10.55 - 21.88
Shares Outstanding (Mil)32.91

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 338 379 412
EPS ($) 0.47 0.73 0.97
EPS without NRI ($) 0.47 0.73 0.97
EPS Growth Rate
(Future 3Y To 5Y Estimate)
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: ----
Positive ROAN
Positive CFROAN
Higher ROA yoyN
Lower Leverage yoyN
Higher Current Ratio yoyN
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyN

» More Articles for SGNT


Articles On GuruFocus.com
NWQ Bought 12 New Holdings in 2nd Quarter Sep 16 2016 

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat